(Q44852570)

6 December 2017

title

Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities (English)

1 reference

6 December 2017

Balasubramaniam P

1

1 reference

6 December 2017

Stevenson O

series ordinal

2

1 reference

6 December 2017

Berth-Jones J

series ordinal

3

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

British Journal of Dermatology

6 December 2017

published in

1 reference

6 December 2017

volume

150

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

741-746

1 reference

Therapeutic strategies: rotational therapy and combinations

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0007-0963.2004.05739.X

[Efficacy and safety profile of fumaric acid esters in oral long-term therapy with severe treatment refractory psoriasis vulgaris. A study of 83 patients].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0007-0963.2004.05739.X

The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0007-0963.2004.05739.X

Inhibition of dendritic cell differentiation by fumaric acid esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0007-0963.2004.05739.X

Addition of pentoxifylline could reduce the side effects of fumaric acid esters in the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0007-0963.2004.05739.X

10.1111/J.0007-0963.2004.05739.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference